Insider-Transaktionen

EDGAR

KINGSTONE COMPANIES, INC.

Von Direktoren, Führungskräften und 10-%-Eignern auf den SEC-Formularen 3, 4 und 5 gemeldete Transaktionen, aus dem XML jeder Einreichung gelesen. Codes und ihr Wortlaut stammen von der SEC.

Das Formular 4 ist innerhalb von zwei Geschäftstagen nach der Transaktion einzureichen; die jüngsten Geschäfte sind daher möglicherweise noch nicht gemeldet.

Zeitfenster: Transaktionen ab dem 18. Nov. 2025.

Käufe am offenen Markt (Code P)
4 Transaktionen, 44.502 Aktien
Summe Aktien × Preis je Aktie: 653.414,48
Verkäufe am offenen Markt (Code S)
3 Transaktionen, 22.213 Aktien
Summe Aktien × Preis je Aktie: 441.636,7922

Die Summen addieren die aufgeführten eingereichten Transaktionen; sie zählen das Gemeldete und messen keine Richtung.

1–28 von 28 angezeigt

Insider-Transaktionen, neueste zuerst, wie auf den SEC-Formularen 3, 4 und 5 eingereicht
DatumMeldende PersonCodeErworben oder veräußertAktienPreis je Aktie, wie eingereichtWert (abgeleitet)Aktien danach im BesitzDirekt oder indirektKästchen zu Rule 10b5-1AnmerkungenQuelle
12. Nov. 2026 Eingereicht am 16. Nov. 2026Chen Minlei Officer: Chief Actuary and Senior VP
S

Open market or private sale of non-derivative or derivative security

Common Stock
Veräußert (D)4.44822,7954
101.393,9392

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 101393.9392.

37.469Direkt (D) Nein
F1, F2
  • F1 This transaction was executed in multiple trades at prices ranging from $22.32 to $23.30 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
  • F2 Includes 12,727 shares received pursuant to unvested restricted stock grants. Such shares vest to the extent of 6,520 shares on March 3, 2027, 3,333 shares on June 18, 2027 and 2,874 shares on March 3, 2028.
Einreichung öffnen 0001021771-26-000120 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
12. Nov. 2026 Eingereicht am 16. Nov. 2026Chen Minlei Officer: Chief Actuary and Senior VP
S

Open market or private sale of non-derivative or derivative security

Common Stock
Veräußert (D)4.26522,8002
97.242,853

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 97242.8530.

33.204Direkt (D) Nein
F1, F2
  • F1 This transaction was executed in multiple trades at prices ranging from $22.32 to $23.30 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
  • F2 Includes 12,727 shares received pursuant to unvested restricted stock grants. Such shares vest to the extent of 6,520 shares on March 3, 2027, 3,333 shares on June 18, 2027 and 2,874 shares on March 3, 2028.
Einreichung öffnen 0001021771-26-000120 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
25. Aug. 2026 Eingereicht am 26. Aug. 2026Patten Randy L Officer: CFO, VP and Treasurer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Veräußert (D)5.30920,09
106.657,81

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 106657.81.

40.672Direkt (D) Nein
F1, F2
  • F1 Shares were withheld from vested stock grant to pay the associated withholding taxes.
  • F2 Includes 34,551 shares received pursuant to unvested restricted stock grants. The shares vest to the extent of 1,042 shares on March 3, 2027, 10,822 shares on August 25, 2027, 1,042 shares on March 3, 2028 and 21,645 shares on August 25, 2028.
Einreichung öffnen 0001021771-26-000113 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
18. Juni 2026 Eingereicht am 23. Juni 2026Chen Minlei Officer: Chief Actuary and Senior VP
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Veräußert (D)1.20215,89
19.099,78

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 19099.78.

41.917Direkt (D) Nein
F1, F2
  • F1 Shares were withheld from vested stock grant to pay the associated withholding taxes.
  • F2 Includes 12,727 shares received pursuant to unvested restricted stock grants. Such shares vest to the extent of 6,520 shares on March 3, 2027, 3,333 shares on June 18, 2027 and 2,874 shares on March 3, 2028.
Einreichung öffnen 0001021771-26-000095 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
29. Mai 2026 Eingereicht am 1. Juni 2026Newgarden Thomas Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Erworben (A)8.00014,9947
119.957,6

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 119957.6000.

99.366Direkt (D) Nein
F2, F1
  • F2 This transaction was executed in multiple trades at prices ranging from $14.97 to $15.00 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
  • F1 Includes 3,149 unvested shares received as director fees. Such shares vest on January 2, 2027, subject to earlier vesting under certain circumstances.
Einreichung öffnen 0001021771-26-000086 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
28. Mai 2026 Eingereicht am 1. Juni 2026Newgarden Thomas Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Erworben (A)6.00015,50
93.000

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 93000.00.

91.366Direkt (D) Nein
F1
  • F1 Includes 3,149 unvested shares received as director fees. Such shares vest on January 2, 2027, subject to earlier vesting under certain circumstances.
Einreichung öffnen 0001021771-26-000086 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
13. Mai 2026 Eingereicht am 13. Mai 2026Newgarden Thomas Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Erworben (A)15.20114,36
218.286,36

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 218286.36.

85.366Direkt (D) Nein
F3, F2
  • F3 This transaction was executed in multiple trades at prices ranging from $14.15 to $14.60 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
  • F2 Includes 3,149 unvested shares received as director fees. Such shares vest on January 2, 2027, subject to earlier vesting under certain circumstances.
Einreichung öffnen 0001021771-26-000070 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
12. Mai 2026 Eingereicht am 13. Mai 2026Newgarden Thomas Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Erworben (A)15.30114,52
222.170,52

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 222170.52.

70.165Direkt (D) Nein
F1, F2
  • F1 This transaction was executed in multiple trades at prices ranging from $13.97 to $14.75 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
  • F2 Includes 3,149 unvested shares received as director fees. Such shares vest on January 2, 2027, subject to earlier vesting under certain circumstances.
Einreichung öffnen 0001021771-26-000070 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. Apr. 2026 Eingereicht am 17. Apr. 2026Yankus William L Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Veräußert (D)13.50018,00
243.000

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 243000.00.

84.972Direkt (D) Ja
F1, F2
  • F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025.
  • F2 Includes 3,149 unvested shares received as director fees. Such shares vest on January 2, 2027, subject to earlier vesting under certain circumstances.
Einreichung öffnen 0001021771-26-000047 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
15. Apr. 2026 Eingereicht am 20. Apr. 2026BRODSKY VICTOR J Officer: Chief Accounting Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Veräußert (D)2.45316,61
40.744,33

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 40744.33.

62.341Direkt (D) Nein
F1, F2
  • F1 Shares were withheld from vested stock grant to pay the associated withholding taxes.
  • F2 Includes 14,055 shares received pursuant to unvested restricted stock grants. Such shares vest to the extent of 2,028 shares on March 3, 2027, 5,000 shares on April 15, 2027, 2,027 shares on March 3, 2028 and 5,000 shares on April 15, 2028.
Einreichung öffnen 0001021771-26-000051 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
3. März 2026 Eingereicht am 16. März 2026Chen Minlei Officer: Chief Actuary and Senior VP
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)8.6240—41.298Direkt (D) Nein
F1, F2
  • F1 Shares received pursuant to restricted stock grant.
  • F2 Includes 16,060 shares received pursuant to unvested restricted stock grants. Such shares vest to the extent of 3,333 shares on June 18, 2026, 6,520 shares on March 3, 2027, 3,333 shares on June 18, 2027 and 2,874 shares on March 3, 2028.
Einreichung öffnen 0001021771-26-000032 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
3. März 2026 Eingereicht am 16. März 2026Chen Minlei Officer: Chief Actuary and Senior VP
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Veräußert (D)1.51216,53
24.993,36

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 24993.36.

39.786Direkt (D) Nein
F3, F2
  • F3 Shares were withheld from vested stock grant to pay the associated withholding taxes.
  • F2 Includes 16,060 shares received pursuant to unvested restricted stock grants. Such shares vest to the extent of 3,333 shares on June 18, 2026, 6,520 shares on March 3, 2027, 3,333 shares on June 18, 2027 and 2,874 shares on March 3, 2028.
Einreichung öffnen 0001021771-26-000032 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
3. März 2026 Eingereicht am 16. März 2026Chen Minlei Officer: Chief Actuary and Senior VP
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Erworben (A)3.3332,25
7.499,25

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 7499.25.

43.119Direkt (D) Nein
F2
  • F2 Includes 16,060 shares received pursuant to unvested restricted stock grants. Such shares vest to the extent of 3,333 shares on June 18, 2026, 6,520 shares on March 3, 2027, 3,333 shares on June 18, 2027 and 2,874 shares on March 3, 2028.
Einreichung öffnen 0001021771-26-000032 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
3. März 2026 Eingereicht am 16. März 2026Chen Minlei Officer: Chief Actuary and Senior VP
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivatives Wertpapier: Stock Option — Basiswert Common Stock (6.666) — Ausübungspreis 2.25
Veräußert (D)3.3330—3.333Direkt (D) Nein
F4
  • F4 The option vests and becomes exercisable to the extent of 3,333 shares on each of January 5, 2026 and January 5, 2027.
Einreichung öffnen 0001021771-26-000032 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
3. März 2026 Eingereicht am 5. März 2026Chen Minlei Officer: Chief Actuary and Senior VP
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)8.6240—37.964Direkt (D) Nein
F1, F2
  • F1 Shares received pursuant to restricted stock grant.
  • F2 Includes 16,060 shares received pursuant to unvested restricted stock grants. Such shares vest to the extent of 3,333 shares on June 18, 2026, 6,520 shares on March 3, 2027, 3,333 shares on June 18, 2027 and 2,874 shares on March 3, 2028.
Einreichung öffnen 0001021771-26-000026 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
3. März 2026 Eingereicht am 5. März 2026Chen Minlei Officer: Chief Actuary and Senior VP
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Veräußert (D)1.51216,53
24.993,36

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 24993.36.

36.452Direkt (D) Nein
F3, F2
  • F3 Shares were withheld from vested stock grant to pay the associated withholding taxes.
  • F2 Includes 16,060 shares received pursuant to unvested restricted stock grants. Such shares vest to the extent of 3,333 shares on June 18, 2026, 6,520 shares on March 3, 2027, 3,333 shares on June 18, 2027 and 2,874 shares on March 3, 2028.
Einreichung öffnen 0001021771-26-000026 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
3. März 2026 Eingereicht am 4. März 2026Patten Randy L Officer: CFO, VP and Treasurer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)3.1260—46.416Direkt (D) Nein
F1, F2
  • F1 Shares received pursuant to restricted stock grant.
  • F2 Includes 45,374 shares received pursuant to unvested restricted stock grants. The shares vest to the extent of 10,823 shares on August 25, 2026, 1,042 shares on March 3, 2027, 10,822 shares on August 25, 2027, 1,042 shares on March 3, 2028 and 21,645 shares on August 25, 2028.
Einreichung öffnen 0001021771-26-000024 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
3. März 2026 Eingereicht am 4. März 2026Patten Randy L Officer: CFO, VP and Treasurer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Veräußert (D)43516,53
7.190,55

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 7190.55.

45.981Direkt (D) Nein
F3, F2
  • F3 Shares were withheld from vested stock grant to pay the associated withholding taxes.
  • F2 Includes 45,374 shares received pursuant to unvested restricted stock grants. The shares vest to the extent of 10,823 shares on August 25, 2026, 1,042 shares on March 3, 2027, 10,822 shares on August 25, 2027, 1,042 shares on March 3, 2028 and 21,645 shares on August 25, 2028.
Einreichung öffnen 0001021771-26-000024 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
3. März 2026 Eingereicht am 4. März 2026BRODSKY VICTOR J Officer: Chief Accounting Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)6.0830—65.639Direkt (D) Nein
F1, F2
  • F1 Shares received pursuant to restricted stock grant.
  • F2 Includes 19,055 shares received pursuant to unvested restricted stock grants. Such shares vest to the extent of 5,000 shares on April 15, 2026, 2,028 shares on March 3, 2027, 5,000 shares on April 15, 2027, 2,027 shares on March 3, 2028 and 5,000 shares on April 15, 2028.
Einreichung öffnen 0001021771-26-000022 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
3. März 2026 Eingereicht am 4. März 2026BRODSKY VICTOR J Officer: Chief Accounting Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Veräußert (D)84516,53
13.967,85

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 13967.85.

64.794Direkt (D) Nein
F3, F2
  • F3 Shares were withheld from vested stock grant to pay the associated withholding taxes.
  • F2 Includes 19,055 shares received pursuant to unvested restricted stock grants. Such shares vest to the extent of 5,000 shares on April 15, 2026, 2,028 shares on March 3, 2027, 5,000 shares on April 15, 2027, 2,027 shares on March 3, 2028 and 5,000 shares on April 15, 2028.
Einreichung öffnen 0001021771-26-000022 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
9. Jan. 2026 Eingereicht am 9. Jan. 2026Golden Meryl S. Director · Officer: CEO, President
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)40.0000—261.675Direkt (D) Nein
F5, F6
  • F5 Shares received pursuant to restricted stock grant. Such shares vest on January 9, 2027.
  • F6 Includes 60,000 shares received pursuant to unvested restricted stock grants. Such shares vest to the extent of 20,000 shares on December 31, 2026 and 40,000 shares on January 9, 2027.
Einreichung öffnen 0001021771-26-000012 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
2. Jan. 2026 Eingereicht am 9. Jan. 2026Golden Meryl S. Director · Officer: CEO, President
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Veräußert (D)7.73516,83
130.180,05

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 130180.05.

221.675Direkt (D) Nein
F3, F4
  • F3 Shares were withheld from vested stock grant to pay associated withholding taxes.
  • F4 Includes 20,000 shares received pursuant to unvested restricted stock grant. Such shares vest on December 31, 2026.
Einreichung öffnen 0001021771-26-000012 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
2. Jan. 2026 Eingereicht am 6. Jan. 2026Yankus William L Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)3.1490—98.472Direkt (D) Nein
F1, F2
  • F1 Received as director fees. Vests on January 2, 2027, subject to earlier vesting under certain circumstances.
  • F2 Includes 3,149 unvested shares received as director fees. Such shares vest on January 2, 2027, subject to earlier vesting under certain circumstances.
Einreichung öffnen 0001021771-26-000008 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
2. Jan. 2026 Eingereicht am 6. Jan. 2026Singh Manmohan Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)7.0110—19.228Direkt (D) Nein
F1, F2, F3
  • F1 Received as director fees. Vests on January 2, 2027, subject to earlier vesting under certain circumstances.
  • F2 Includes 7,011 unvested shares received as director fees. Such shares vest on January 2, 2027, subject to earlier vesting under certain circumstances.
  • F3 Funds managed by Angel Oak Capital Advisors (AOCA) hold 108,249 shares of common stock of the Issuer. Mr. Singh serves as Group Chief Financial Officer and Head of Corporate Development of Angel Oak Companies, which is the parent of AOCA. Mr. Singh disclaims beneficial ownership of such securities.
Einreichung öffnen 0001021771-26-000010 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
2. Jan. 2026 Eingereicht am 5. Jan. 2026Tupper Floyd R Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)3.1490—118.476Direkt (D) Nein
F1, F2
  • F1 Received as director fees. Vests on January 2, 2027, subject to earlier vesting under certain circumstances.
  • F2 Includes 3,149 unvested shares received as director fees. Such shares vest on January 2, 2027, subject to earlier vesting under certain circumstances.
Einreichung öffnen 0001021771-26-000004 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
2. Jan. 2026 Eingereicht am 5. Jan. 2026Pasricha Pranav Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)7.0110—8.547Direkt (D) Nein
F1, F2
  • F1 Received as director fees. Vests on January 2, 2027, subject to earlier vesting under certain circumstances.
  • F2 Includes 7,011 unvested shares received as director fees. Such shares vest on January 2, 2027, subject to earlier vesting under certain circumstances.
Einreichung öffnen 0001021771-26-000006 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
2. Jan. 2026 Eingereicht am 5. Jan. 2026Newgarden Thomas Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)3.1490—54.864Direkt (D) Nein
F1, F2
  • F1 Received as director fees. Vests on January 2, 2027, subject to earlier vesting under certain circumstances.
  • F2 Includes 3,149 unvested shares received as director fees. Such shares vest on January 2, 2027, subject to earlier vesting under certain circumstances.
Einreichung öffnen 0001021771-26-000002 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
31. Dez. 2025 Eingereicht am 9. Jan. 2026Golden Meryl S. Director · Officer: CEO, President
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)1.66312,78
21.253,14

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 21253.14.

229.410Direkt (D) Nein
F1, F2
  • F1 The shares were acquired pursuant to the Company's Employee Stock Purchase Plan.
  • F2 Includes 40,000 shares received pursuant to unvested restricted stock grant. Such shares vest to the extent of 20,000 shares on January 2, 2026 and 20,000 shares on December 31, 2026.
Einreichung öffnen 0001021771-26-000012 Aus dem XML der Einreichung gelesen Diese Zeile anfechten

Institutionelle Halter (Formular 13F)

Im Speicher ist dieser Emittent keiner Form-13F-Position zugeordnet. Ein noch nicht verknüpfter oder noch nicht meldender Halter fehlt, er steht nicht bei null.

5-%-Halter (Schedule 13D und 13G)

Hier werden im strukturierten SEC-Format (ab Ende 2024) eingereichte Schedules gelesen. Frühere sind Freitext und werden nicht gelesen.

5-%-Halter, jüngstes Ereignis zuerst, wie eingereicht
HalterProzent der GattungGehaltene AktienEreignisdatumFormularQuelle
Gregory Fortunoff Common Stock, $0.01 par value per share5.9848.650,0003/05/2026 Eingereicht am 12. März 2026SCHEDULE 13DEinreichung öffnen 0001104659-26-027102 Diese Zeile anfechten
Scott Fortunoff Common Stock, $0.01 par value per share1.7240.660,0003/05/2026 Eingereicht am 12. März 2026SCHEDULE 13DEinreichung öffnen 0001104659-26-027102 Diese Zeile anfechten
BlackRock, Inc. Common Stock5.5776.25809/30/2025 Eingereicht am 17. Okt. 2025SCHEDULE 13GEinreichung öffnen 0002012383-25-002876 Diese Zeile anfechten
Gregory Fortunoff Common Stock, $0.01 par value per share5.8825.300,0009/02/2025 Eingereicht am 12. Sept. 2025SCHEDULE 13G/AÄnderung 1Einreichung öffnen 0001104659-25-089437 Diese Zeile anfechten
Scott Fortunoff Common Stock, $0.01 par value per share1.4201.000,0009/02/2025 Eingereicht am 12. Sept. 2025SCHEDULE 13G/AÄnderung 1Einreichung öffnen 0001104659-25-089437 Diese Zeile anfechten
Gregory Fortunoff Common Stock, $0.01 par value per share4.4611.905,0006/06/2025 Eingereicht am 25. Juni 2025SCHEDULE 13GEinreichung öffnen 0001104659-25-062654 Diese Zeile anfechten
Scott Fortunoff Common Stock, $0.01 par value per share1.6231.000,0006/06/2025 Eingereicht am 25. Juni 2025SCHEDULE 13GEinreichung öffnen 0001104659-25-062654 Diese Zeile anfechten

Der Prozentsatz bezieht sich auf die in der Einreichung genannte Gattung, wie vom Halter angegeben. Gruppenmitglieder melden jeweils die Aktien der Gruppe; die Zeilen werden daher nicht addiert.

Was gelesen wurde

2.241.208 Einreichungen gelesen, vom 14. Juni 2004 bis 17. Nov. 2026: Formulare 3, 3/A, 4, 4/A, 5, 5/A.

Jahre können unvollständig sein, solange das Archiv noch gelesen wird. Ein Jahr mit wenigen Einreichungen hier besagt nicht, dass wenige gemacht wurden.

Gelesene Einreichungen nach Einreichungsjahr
EinreichungsjahrGelesene Einreichungen
20151
2016204.322
2017202.494
2018202.048
2019193.638
2020144.184
2021224.474
2022158.941
2023199.811
2024209.823
2025235.520
2026260.174

Einreichungen aus der Zeit vor der XML-Pflicht der SEC sind aufgeführt, aber nicht ausgelesen.

Zurück zu KINGSTONE COMPANIES, INC.